Zhenyan Han

Dr. Zhenyan Han


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2022 in Frontiers in Surgery
Verified
Journal Article
Open access
YZYuan Zhang
Yuan Zhang
QWQingqing Wang
Qingqing Wang
ZTZhangmin Tan
Zhangmin Tan
JZJin Zhou
Jin Zhou
PZPeizhen Zhang
Peizhen Zhang
ZHZhenyan Han
Zhenyan Han
The purpose of this study was to investigate the role of amnioreduction in patients who underwent emergency cervical cerclage (ECC) with bulging membranes during the second trimester. This retrospective comparative study included 46 singleton pregnant women who had cervical dilation at least 1 cm with bulging membranes beyond the external cervical os and underwent ECC at the Third Affiliated Hospital of Sun Yat-sen University between December 2016 and December 2021. Cases were categorized as amnioreduction group (n = 16) and non-amnioreduction group (n = 30) according to whether amnioreduction was performed prior to ECC. The gestational age and cervical dilation at cerclage, operative time, prolongation of pregnancy, and outcomes of pregnancy were compared between the two groups. All 46 patients underwent successful ECC excepted one case with intraoperative rupture of membrane in non-amnioreduction group. In the amnioreduction group, the cervical dilation at cerclage was larger than that in the non-amnioreduction group (4.5 ± 2.2 vs. 2.2 ± 1.2 cm, P < 0.001), and had more patients with cervical dilation ≥4 cm (50.0% vs. 10.0%, P = 0.004). However, the gestational age at cerclage, operative time, prolongation of pregnancy, gestational age at delivery were not significantly different between the two groups (22.9 ± 2.8 vs. 22.9 ± 3.2 weeks, 31.1 ± 9.2 vs. 27.9 ± 11.4 min, 21.3 ± 21.5 vs. 38.7 ± 40.2 days, 25.9 ± 4.5 vs. 28.4 ± 6.1 weeks; P > 0.05). The rates of delivery ≥28 weeks, ≥32 weeks, and live birth were 20.0% vs. 80.0%, 12.5% vs. 26.7%, 56.3% vs. 66.7% (P > 0.05) in amnioreduction group and non-amnioreduction group, respectively. In conclusion, even in cases with larger cervical dilation, the application of amnioreduction with ECC is possible to get the acceptable pregnancy outcomes. These findings suggested that amnioreduction may be a safe and feasible option to be applied before ECC, especially for those with advanced cervical dilation and bulging membranes.

1 March 2025 in The Visual Computer
Verified
Journal Article
Closed access
PDF file
XZXuefeng Zhang
Xuefeng Zhang
BYBin Yan
Bin Yan
ZXZhaohu Xing
Zhaohu Xing
FGFeng Gao
Feng Gao
YTYuandong Tao
Yuandong Tao
LZLei Zhu
Lei Zhu

14 March 2026 in Medical Image Analysis
Verified
Journal Article
Closed access
Jieyun BaiJieyun Bai
Jieyun Bai
ZZZihao Zhou
Zihao Zhou
YTYitong Tang
Yitong Tang
JGJie Gan
Jie Gan
ZLZhuonan Liang
Zhuonan Liang
SLShuo Li
Shuo Li

11 September 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JZJin Zhou
Jin Zhou
PZPeizhen Zhang
Peizhen Zhang
ZTZhangmin Tan
Zhangmin Tan
CLChuo Li
Chuo Li
LYLin Yao
Lin Yao
YYYuzhu Yin
Yuzhu Yin
This study aims to analyze whether undergoing amniocentesis during pregnancy in women diagnosed with hepatitis B virus (HBV) infection leads to HBV transmission to newborns. Retrospective data collection was conducted from June 2019 to November 2022 on expectant mothers positive for hepatitis B surface antigen (HBsAg) who underwent amniocentesis at The Third Affiliated Hospital of Sun Yat-sen University, along with data on their newborns. The study summarized the HBV infection status of newborns born to mothers with different expressions of hepatitis B e antigen (HBeAg), antiviral treatment versus no treatment, and different HBV DNA viral loads before delivery. In this study, 346 expectant mothers tested positive for HBsAg, along with 351 newborns (including 5 sets of twins, with 8 infants (2.28%) testing HBsAg-positive at birth. All newborns received dual immunotherapy and were followed up. At 7–12 months, retesting for HBsAg positivity and HBV DNA positivity among infants revealed that out of the infants born with HBsAg positivity, 7 cases had seroconverted to negative, while the remaining infant, who was positive for both HBsAg and HBeAg at birth, tested positive for both HBsAg and HBV DNA at 7–12 months. Thus, one case of vertical transmission of hepatitis B from mother to child occurred in this study. The proportion of infants born with HBsAg + among newborns born to HBeAg-positive mothers (4 cases, 6.06%) was significantly higher than that among newborns born to HBeAg-negative mothers (4 cases, 1.41%) (P < 0.05). The proportion of infants born with HBsAg + showed no significant difference between newborns born to mothers receiving antiviral therapy (2 cases, 2.90%) and those born to mothers not receiving antiviral therapy (6 cases, 2.13%) (P > 0.05). Among expectant mothers with viral load ≥ 6 log 10 IU/mL before delivery, 3 newborns (30.00%) were manifesting HBsAg positivity at birth, significantly higher than the group with viral load < 6 log 10 IU/mL before delivery (5 cases, 1.47%) (P < 0.05). Among HBsAg-positive expectant mothers, only a small number of infants are infected with the hepatitis B virus at birth, the proportion of which is relatively low. Infants born to mothers who are HBeAg-positive or have a viral load ≥ 6 log10 IU/mL have a higher risk of being born positive.

14 August 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
GWGuan Wang
Guan Wang
WCWeifen Chen
Weifen Chen
XCXiaodan Chen
Xiaodan Chen
HHHongying Hou
Hongying Hou
ZHZhenyan Han
Zhenyan Han
ZHZhenyan Han
Zhenyan Han
Background: Detecting microbes in amniotic fluids via amniocentesis represents the standard method for diagnosing intrauterine infections. Given its similarity to metagenomic next-generation sequencing, copy number variation sequencing (CNV-seq) data may also contain microbial sequences. This exploratory study aimed to investigate the feasibility of prenatal CNV-seq for detecting Ureaplasma parvum (U. parvum) in amniotic fluids and to evaluate the pregnancy outcomes in U. parvum-positive cases.Methods: This retrospective study enrolled 2419 singleton pregnant women who underwent genetic amniocentesis for fetal CNV-seq testing and completed the follow-up with documented pregnancy outcomes. The CNV-seq data were reanalyzed to extract the read counts of U. parvum from each sample’s raw data, and reads per million (RPM) was used to quantify its relative abundance.Results: The prevalence of asymptomatic intrauterine U. parvum positivity in this cohort was 1.4% (33/2419), with read counts ranging 1 to 30423 and RPM from 0.09 to 3580.65 by reanalysis of CNV-seq data. There was a statistically significantly higher risk for early spontaneous preterm labor (<32 gestational weeks; P<0.001) and preterm premature rupture of the membranes (P<0.001) in women with positive U. parvum compared to negative cases. Among U. parvum positive cases, six cases (6/33, 18.2%) had relatively higher read counts ranging from 2483 to 30423, with corresponding RPM of 406.45 to 3580.65. Adverse pregnancy outcomes were exclusively observed among women with high reads of U. parvum as opposed to those with low reads. Four cases with high U. parvum reads in amniotic fluids, not treated with antibiotics, showed a latency period of 6 to 10 weeks from positive detection to the onset of clinical manifestations.Conclusions: CNV-seq may be a feasible method for detecting intraamniotic U. parvum infection. High abundance of asymptomatic U. parvum in amniotic fluids are statistically associated with adverse pregnancy outcomes, highlighting its importance in preliminary screening.

23 June 2026 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
MDMin Du
Min Du
LZLinjia Zhong
Linjia Zhong
PHPing Hu
Ping Hu
MHMinli Huang
Minli Huang
SWShuzhen Wu
Shuzhen Wu
LWLingling Wu
Lingling Wu
Labor neuraxial analgesia (NA) is considered the gold standard for labor pain management worldwide, yet its use remains low in China. This study aimed to evaluate the barriers and facilitators regarding the use of NA from the perspectives of pregnant women and their partners. A cross-sectional survey using a knowledge-attitude-practice (KAP) questionnaire was conducted in 13 hospitals from April to December 2022. A total of 1,164 pairs of pregnant women and their partners attending prenatal care clinics were recruited using a convenience sampling technique. Data were analyzed using univariate analysis and multivariable linear regression. Both pregnant women and their partners exhibited a lack of knowledge about NA, and online information and communicating with others were the primary ways to learn about NA. Multivariable regression indicated education level (B = 1.33, 95% confidence interval [CI]: 0.94-1.73), gestational age (B = 1.29, 95% CI: 0.96-1.63), hospital level 2 (B = 1.73, 95% CI: 0.73-2.73), level 3 (B = 2.11, 95% CI: 1.25-2.97), and parity (B = 1.32, 95% CI: 0.68-1.97) influenced pregnant women's knowledge. Similarly, education level (B = 1.04, 95% CI: 0.66-1.42) and gestational age (B = 0.68, 95% CI:0.33-1.03) were positively associated with their partners' knowledge. For pregnant women, annual income (B = 1.39, 95% CI: 0.72-2.05) and parity (B = -1.43, 95% CI: -2.71- -0.15) affected attitudes, while gestational age (B = 0.67, 95% CI: 0.23-1.11), annual income (B = 1.18, 95% CI: 0.57-1.79) and parity (B = -1.43, 95% CI: -2.61- -0.26) affected in practice. For partners, hospital level and age positively influenced attitudes and practice towards NA. Most concerns regarding NA were attributed to inadequate awareness and misconception about the safety of NA. Knowledge regarding NA was found to be inadequate among both pregnant women and their partners, while annual income, parity, hospital level and age were the influencing factors regarding attitudes and practice. Online hospital-based educational programs incorporating tailored information about NA could potentially improve the decision-making process of NA in China.